With the accelerating global aging population, the burden of neurodegenerative diseases continues to rise, placing substantial economic and caregiving pressure on both society and families. Non-invasive neuromodulation (NINM) has emerged as a potential intervention, demonstrating unique advantages in mitigating functional decline. However, a scientific, comprehensive, and standardized system is still lacking in the current evaluation of effects and efficacy, as they rely heavily on subjective scales, overlook the dynamic changes of brain function, and involve ambiguous safety thresholds, thereby constraining comprehensive assessment of the long-term efficacy and clinical benefits of NINM. Based on evidence-based medicine, domestic and international guidelines, expert consensus, clinical practical experience, and technical management standards, this consensus statement proposes 11 recommendations for NINM interventions targeting elderly individuals with disability and dementia. These recommendations systematically encompass key domains including patient selection, intervention strategies, efficacy and effectiveness evaluation, and safety monitoring. The development of this consensus aims to enhance the scientific rigor and feasibility of clinical application, providing standardized guidance for NINM interventions in elderly populations with disability and dementia, thus ensuring their rational implementation and effective management in clinical practice.